The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2

The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2

The receptor-binding domain (RBD) of the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the human angiotensin-converting enzyme 2 (ACE2) receptor, which is a prerequisite for the virus to enter the cell. C-reactive protein (CRP) is an important marker of infla...

Full description

Bibliographic Details
Main Authors:	Hai-yun Li, Ning Gao, Cheng-yang Liu, Xiao-ling Liu, Feng Wu, Nini Dai, Jing Han, Qiu-yu Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 monomeric C-reactive protein pattern recognition receptor ACE2 cholesterol-binding sequence
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.918731/full

Similar Items

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2
by: Hai-yun Li, et al.
Published: (2022-09-01)

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2
by: Ting Wang, et al.
Published: (2022-09-01)

The Effects of Aβ<sub>1-42</sub> Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2
by: John Tsu-An Hsu, et al.
Published: (2021-07-01)

C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor
by: Manu Sudhakar, et al.
Published: (2018-05-01)

Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme
by: Marco Pitino, et al.
Published: (2022-12-01)

Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
by: K. J. Senthil Kumar, et al.
Published: (2020-06-01)

Soluble angiotensin-converting enzyme 2 association with lipid metabolism
by: Izumi Nagatomo, et al.
Published: (2022-08-01)

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
by: Damiano Buratto, et al.
Published: (2021-11-01)

Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
by: Weitong Yao, et al.
Published: (2023-12-01)

Improved Binding Affinity of Omicron’s Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence
by: Rajender Kumar, et al.
Published: (2022-03-01)

Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
by: Gennady Verkhivker
Published: (2020-11-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial
by: Mardin Rashid, et al.
Published: (2018-07-01)

Multifaceted membrane binding head of the SARS-CoV-2 spike protein
by: Anh Tran, et al.
Published: (2022-01-01)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
by: Marine E. Bozdaganyan, et al.
Published: (2022-01-01)

Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor
by: Deborah Giordano, et al.
Published: (2021-08-01)

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium
by: Simon D. Pouwels, et al.
Published: (2023-05-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
by: Si Zhang, et al.
Published: (2020-09-01)

A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response
by: Woong Kim, et al.
Published: (2024-03-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition
by: Lorenzo Di Rienzo, et al.
Published: (2021-01-01)

Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
by: Ratul Chowdhury, et al.
Published: (2020-01-01)

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
by: Peng Sang, et al.
Published: (2022-11-01)

SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells
by: Dante Barreda, et al.
Published: (2021-11-01)

Cholesterol binding to ion channels
by: Irena eLevitan, et al.
Published: (2014-02-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
by: Thomas A. Strong, et al.
Published: (2021-12-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review
by: Bhagat Singh, et al.
Published: (2022-04-01)

CORRELATION BETWEEN ANGIOTENSIN-CONVERTING ENZYME INHIBITORS LIPOPHILICITY AND PROTEIN BINDING DATA
by: Jasna Trbojević-Stanković, et al.
Published: (2012-01-01)

SARS-CoV-2 omicron spike simulations: broad antibody escape, weakened ACE2 binding, and modest furin cleavage
by: M. Zaki Jawaid, et al.
Published: (2023-10-01)

Molecular docking study and mapping the binding site of some antiviral nanobodies against receptor binding domain (RBD) of SARS-COV 2
by: zahra pahlavan, et al.
Published: (2021-06-01)

On the binding affinity and thermodynamics of sodium alginate-heavy metal ion interactions for efficient adsorption
by: Chantal Mohammed, et al.
Published: (2022-06-01)

Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency
by: Kaiyuan Shi, et al.
Published: (2024-02-01)

Purification and Characterization of Porcine Angiotensin Converting Enzyme 2
by: Weiwei LIU, et al.
Published: (2022-09-01)

Monomeric compounds from traditional Chinese medicine: New hopes for drug discovery in pulmonary fibrosis
by: Qi Wang, et al.
Published: (2023-03-01)

Angiotensin-Converting Enzyme 2 SNPs as Common Genetic Loci and Optimal Early Identification Genetic Markers for COVID-19
by: Yan Ma, et al.
Published: (2022-08-01)

Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
by: Yong Jin, et al.
Published: (2021-11-01)

Mulberrofuran G, a Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor
by: Young Soo Kim, et al.
Published: (2022-10-01)